Inactive Instrument

Press Releases BioLargo, Inc. OTC Bulletin Board

Equities

US09065A1007

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

05-14	Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024
05-14	BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

BioLargo to Present at The LD Micro Invitational XIV	03-25	NE
New Regulations May Be Coming To Combat Dangerous “Forever Chemicals” – This Cleantech Innovator Is Ready	02-22	AQ
BioLargo, Inc. to Present at the LD Micro Main Event XVI	23-09-19	NE
BioLargo, Inc. Discusses Record-Breaking Financial Results, Innovation-Pipeline Business Model, and More with The Stock Day Podcast	23-06-05	NE
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-05-18	AQ
0:00:05.7 Dennis Calvert: Today. What's up? Dennis Calvert - Form 8-K	23-05-09	PU
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-05-09	AQ
BioLargo to Present at the Sequire Investor Summit in Puerto Rico	23-04-24	AQ
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-04-04	AQ
BIOLARGO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-31	AQ
BioLargo, Inc. Discusses 125% Revenue Increase and Significance of Proposed EPA PFAS Regulations with The Stock Day Podcast	23-03-29	NE
BIOLARGO, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-03-27	AQ
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-03-20	AQ
BioLargo, Inc. Discusses 125% Revenue Increase for 2022 with The Stock Day Podcast	23-01-31	NE
BIOLARGO, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	22-12-19	AQ
BIOLARGO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-14	AQ
BioLargo : Adds Linda Park and Christina Bray to Board of Directors - Form 8-K	22-11-03	PU
BIOLARGO, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-11-03	AQ
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-10-31	AQ
BioLargo, Inc. Discusses Its PFAS Treatment Solution and Odor Control Technology with The Stock Day Podcast	22-10-25	NE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases BioLargo, Inc. OTC Bulletin Board

Equities

US09065A1007

Press Releases

Filters